- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07921914
Dietary Supplementation and Hydration
This study will examine the effects of protein drinks on markers of hydration in healthy young males and females.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Leicestershire
-
Loughborough, Leicestershire, United Kingdom
- Loughborough University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy, physically active
Exclusion Criteria:
Are not between the ages of 18-40. If you are not considered at least recreationally physically active (at least meeting the WHO criteria) - Tier 1 or Tier 2 on the Participant Classification Framework (https://pubmed.ncbi.nlm.nih.gov/34965513/).
Have metabolic, inflammatory, vascular, renal disease or any other complication that would contradict the study procedures or risk your health.
Currently taking medication or supplements that may interfere with the study outcomes.
- Do not satisfactorily complete the health history survey
- You have any allergies to the ingredients in the supplements
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Protein
Protein (10 g of protein powder and 500 ml of water) |
10 g of protein powder in 500 ml water 10 g of protein powder, plus sodium chloride (20 mmol/L) in 500 ml of water |
|
Experimental: Protein+
Protein (10 g of protein powder, 500 ml of water, sodium chloride, 20 mmol/L) |
10 g of protein powder in 500 ml water 10 g of protein powder, plus sodium chloride (20 mmol/L) in 500 ml of water |
|
Placebo Comparator: Placebo control
Water (500 ml) |
Water (500 ml) |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Urine output (mass in grams over 180 min collection period)
Time Frame: 180 minutes
|
180 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective measures of thirst (Likert scale, 0-10; 0 = low, 10 = high)
Time Frame: Pre - then 30, 60, 120, 180 mins post
|
Pre - then 30, 60, 120, 180 mins post
|
|
|
Urine specific gravity (AU)
Time Frame: Pre - then 60, 120, 180 mins post
|
Pre - then 60, 120, 180 mins post
|
|
|
Blood sodium concentrations (mmol)
Time Frame: Pre - then 30, 60, 120, 180 mins post
|
Pre - then 30, 60, 120, 180 mins post
|
|
|
Blood chloride concentrations (mmol)
Time Frame: Pre - then 30, 60, 120, 180 mins post
|
Pre - then 30, 60, 120, 180 mins post
|
|
|
Blood potassium (mmol)
Time Frame: Pre - then 30, 60, 120, 180 mins post
|
Pre - then 30, 60, 120, 180 mins post
|
|
|
Urine sodium (mmol)
Time Frame: Pre - then 30, 60, 120, 180 mins post
|
Pre - then 30, 60, 120, 180 mins post
|
|
|
Urine chloride (mmol)
Time Frame: Pre - then 30, 60, 120, 180 mins post
|
Pre - then 30, 60, 120, 180 mins post
|
|
|
Urine potassium (mmol)
Time Frame: Pre - then 30, 60, 120, 180 mins post
|
Pre - then 30, 60, 120, 180 mins post
|
|
|
Plasma volume change (% change)
Time Frame: Pre - then 60, 180 minutes
|
Pre - then 60, 180 minutes
|
|
|
Plasma albumin concentrations
Time Frame: Pre - then 60, 180 minutes
|
ELISA measurement |
Pre - then 60, 180 minutes
|
|
Plasma aldosterone concentrations
Time Frame: Pre - then 60, 180 minutes
|
ELISA measurement |
Pre - then 60, 180 minutes
|
|
Subjective measure of hunger (Likert scale, 0-10; 0 = low, 10 = high)
Time Frame: Pre - then 30, 60, 120, 180 mins post
|
Pre - then 30, 60, 120, 180 mins post
|
|
|
Subjective measure of gastrointestinal stress (Likert scale, 0-10; 0 = low, 10 = high)
Time Frame: Pre - then 30, 60, 120, 180 mins post
|
Pre - then 30, 60, 120, 180 mins post
|
|
|
Plasma insulin concentrations
Time Frame: Pre - then 60, 180 minutes
|
ELISA measurement |
Pre - then 60, 180 minutes
|
|
Subjective measures of hunger (Likert scale, 0-10; 0 = low, 10 = high)
Time Frame: Pre - then 30, 60, 120, 180 mins post
|
Pre - then 30, 60, 120, 180 mins post
|
|
|
Subjective measures of stomach fullness (Likert scale, 0-10; 0 = low, 10 = high)
Time Frame: Pre - then 30, 60, 120, 180 mins post
|
Pre - then 30, 60, 120, 180 mins post
|
|
|
Subjective measures of nausea (Likert scale, 0-10; 0 = low, 10 = high)
Time Frame: Pre - then 30, 60, 120, 180 mins post
|
Pre - then 30, 60, 120, 180 mins post
|
|
|
Beverage hydration index (AU)
Time Frame: Pre - then 30, 60, 120, 180 mins post
|
Calculated as the ratio of cumulative urine mass for water/cumulative urine mass of the test beverages |
Pre - then 30, 60, 120, 180 mins post
|
|
Plasma osmolality (mOsm/L)
Time Frame: Pre - 60, 180 mins post
|
Pre - 60, 180 mins post
|
|
|
Blood glucose (mmol/L)
Time Frame: Pre - then 30, 60, 120, 180 mins post
|
Pre - then 30, 60, 120, 180 mins post
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.